Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (1-10 of 359) with videos related to

Pageof 36
Sort By:
Seminars in Oncology|April 1, 1992
Teniposide alone and in combination chemotherapy in small cell lung cancerG Giaccone
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2005
HER1/EGFR-targeted agents: predicting the future for patients with unpredictable outcomes to therapyG Giaccone
British Journal of Hospital Medicine|May 4, 1996
New drugs for the management of lung cancerG Giaccone
Seminars in Oncology|December 1, 1988
The European Organization for Research and Treatment of Cancer (EORTC) trials of new agents for advanced non-small cell lung cancerG Giaccone
European Journal of Cancer (Oxford, England : 1990)|March 13, 2002
State of the art in systemic treatment of lung cancerG Giaccone
Seminars in Oncology|April 14, 1999
Gemcitabine plus taxane combinations in non-small cell lung cancerG Giaccone
Drugs|June 23, 2000
Clinical perspectives on platinum resistanceG Giaccone
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
New drugs in non-small cell lung cancer. An overviewG Giaccone
Pathologie-Biologie|April 1, 1994
DNA topoisomerases and topoisomerase inhibitorsG Giaccone
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Twenty-five years of treating advanced NSCLC: what have we achieved?G Giaccone
Pageof 36

Showing results (1-10 of 359) with videos related to

Sort By:
Pageof 36
Seminars in Oncology|April 1, 1992
Teniposide alone and in combination chemotherapy in small cell lung cancerG Giaccone
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2005
HER1/EGFR-targeted agents: predicting the future for patients with unpredictable outcomes to therapyG Giaccone
British Journal of Hospital Medicine|May 4, 1996
New drugs for the management of lung cancerG Giaccone
Seminars in Oncology|December 1, 1988
The European Organization for Research and Treatment of Cancer (EORTC) trials of new agents for advanced non-small cell lung cancerG Giaccone
European Journal of Cancer (Oxford, England : 1990)|March 13, 2002
State of the art in systemic treatment of lung cancerG Giaccone
Seminars in Oncology|April 14, 1999
Gemcitabine plus taxane combinations in non-small cell lung cancerG Giaccone
Drugs|June 23, 2000
Clinical perspectives on platinum resistanceG Giaccone
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
New drugs in non-small cell lung cancer. An overviewG Giaccone
Pathologie-Biologie|April 1, 1994
DNA topoisomerases and topoisomerase inhibitorsG Giaccone
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Twenty-five years of treating advanced NSCLC: what have we achieved?G Giaccone
Pageof 36